| 000 | 01779ncm a2200337 a 4500 | ||
|---|---|---|---|
| 003 | EG-GiCUC | ||
| 008 | 100404s2010 ua dh f m 000 0 eng d | ||
| 040 |
_aEG-GiCUC _beng _cEG-GiCUC |
||
| 041 | 0 | _aeng | |
| 049 | _aDeposite | ||
| 097 | _aM.Sc | ||
| 099 | _aCai01.11.18.M.Sc.2010.Mo.A | ||
| 100 | 0 | _aMohamed Salah Khalifa | |
| 245 | 1 | 0 |
_aAssociation of pentraxin 3 with etiology , risk factors and severity of heart failure in Cairo university internal medicine intensive care unit / _cMohamed Salah Khalifa ; Supervised Bahaa Demian Metias Grace , Yasser Mohamed Abdelhamid , Reem Jan Farid |
| 246 | 1 | 5 | _aعلاقة البنتركسن 3 باسباب عوامل الخطر وحدة هبوط عضلة القلب فى مرضى لعناية المركزة للامراض الباطنة بجامعة القاهرة |
| 260 |
_aCairo : _bMohamed Salah Khalifa , _c2010 |
||
| 300 |
_a112P. : _bcharts , facsimiles ; _c25cm |
||
| 502 | _aThesis (M.Sc.) - Cairo University - Faculty of Medicine - Department of Internal Medicine | ||
| 520 | _aPlasma pentraxin 3 could be used as a marker for detection of severity of heart failure . Interpretations of plasma pentraxin 3 level need not be corrected for age sex or hypertension diabetes mellitus hyperlipidemia ischemic heart disease rheumatic heart disease or cardiomyopathy as risk factors or etiological factors for heart failure | ||
| 530 | _aIssued also as CD | ||
| 653 | 4 | _aHeart failure | |
| 653 | 4 | _aInternal Medicine | |
| 653 | 4 | _aPentraxin 3 | |
| 700 | 0 |
_aBahaa Demian Metias Grace , _eSupervisor |
|
| 700 | 0 |
_aReem Jan Farid , _eSupervisor |
|
| 700 | 0 |
_aYasser Mohamed Abdelhamid , _eSupervisor |
|
| 902 | _a1 | ||
| 905 |
_aNazla _eRevisor |
||
| 905 |
_aSoheir _eCataloger |
||
| 942 |
_2ddc _cTH |
||
| 999 |
_c29930 _d29930 |
||